https://www.switzerlandhealthmonitor.com/article/907296739-64k-cellssense-expands-in-asia-with-clinique-eden-suisse-collaboration-names-dylan-kuo-ambassador Switzerland Health Monitor en PressRelease 2026-04-24T08:00:00+00:00 64K Cellssense Expands in Asia with Clinique Eden Suisse Collaboration, Names Dylan Kuo Ambassador https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838216-64k-cellssense-shenzhen-gala-ve-1921x1280.jpeg https://www.switzerlandhealthmonitor.com/article/907694096-geneva-college-of-longevity-science-launches-the-world-s-first-phd-in-longevity-sciences Switzerland Health Monitor en PressRelease 2026-04-24T07:40:52+00:00 Geneva College of Longevity Science Launches the World’s First PhD in Longevity Sciences https://ml-eu.globenewswire.com/media/OWQzNGMzY2EtZDhmMi00NGJiLTgzY2MtMmNkZjAwZTJkZjMyLTEzMTkzMzAtMjAyNi0wNC0yNC1lbg==/tiny/GCLS.png https://www.switzerlandhealthmonitor.com/article/907671711-novartis-malaria-treatment-coartem-baby-receives-who-prequalification-paving-way-for-greater-access-for-newborns-and-young-infants Switzerland Health Monitor en PressRelease 2026-04-24T05:15:00+00:00 Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.switzerlandhealthmonitor.com/article/907411627-10zig-baut-technologiepartnerprogramm-aus Switzerland Health Monitor en PressRelease 2026-04-23T09:01:00+00:00 10ZiG baut Technologiepartnerprogramm aus https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24019101-10zig-technology-logo-3362x706.png https://www.switzerlandhealthmonitor.com/article/907482394-aax-biotech-and-evitria-to-expand-access-to-opti-mab-technology-in-early-antibody-development Switzerland Health Monitor en PressRelease 2026-04-23T08:57:07+00:00 AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24839158-aax-and-evitria-partnership-3080x994.jpeg https://www.switzerlandhealthmonitor.com/article/907472300-santhera-ernennt-orlando-oliveira-zum-chief-executive-officer Switzerland Health Monitor en PressRelease 2026-04-23T05:00:00+00:00 Santhera ernennt Orlando Oliveira zum Chief Executive Officer https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.switzerlandhealthmonitor.com/article/907472306-santhera-appoints-orlando-oliveira-as-chief-executive-officer Switzerland Health Monitor en PressRelease 2026-04-23T05:00:00+00:00 Santhera Appoints Orlando Oliveira as Chief Executive Officer https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.switzerlandhealthmonitor.com/article/907294682-altimetrik-partners-with-google-cloud-to-scale-enterprise-ai Switzerland Health Monitor en PressRelease 2026-04-22T12:30:00+00:00 Altimetrik Partners with Google Cloud to Scale Enterprise AI https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838194-raj-sundaresan-1600x2400.jpeg